Former Ripple CTO Schwartz Reacts As XRP Launches Official X Account
One of XRP’s most prominent figures had something to say about the new account representing the digital asset on X.
David Schwartz, Ripple’s CTO Emeritus and co-architect of the XRP Ledger, responded to the XRP account’s debut post with a playful question: “Time for the Grateful Dead to create an @XRP song?”
The remark carries a layer of history. Schwartz is not publicly known as a Grateful Dead fan himself, but the band has a genuine connection to Ripple’s story.
Ripple acquired its domain, ripple.com, from a Grateful Dead fan who had registered it years earlier because of the band’s song “Ripple.” That connection has been part of Ripple’s lore ever since.
XRP Makes its X Debut
The account amassed tens of thousands of followers within hours of going live, and had almost 87k followers at press time. Before this, the community often engaged with the official Ripple account, its executives, or with the Cashtags introduced to X earlier in the year. Despite XRP’s status as one of the most recognized digital assets in the world, it had no dedicated official X presence before today.
Schwartz’s Reaction
He quoted the new account’s first message and posed his Grateful Dead question to his followers. The joke landed well, given the band’s existing tie to Ripple’s origin story.
It also shows Schwartz maintaining his presence in the XRP community following his transition away from the CTO role at the end of 2025.
The Community Runs With It
The XRP community picked up on Schwartz’s post and took it further.
Multiple community members shared AI-generated Grateful Dead songs about XRP. The community often turns to AI to generate media concerning XRP and its history.
The Grateful Dead link to Ripple has existed since the company’s earliest days, but the responses go beyond that. It shows a community very excited for another way to engage with XRP.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.
Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks
Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.


